Medifast Inc [MED] stock is trading at $14.58, down -0.27%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The MED shares have gain 8.64% over the last week, with a monthly amount glided 7.13%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Medifast Inc [NYSE: MED] stock has seen the most recent analyst activity on November 05, 2024, when DA Davidson upgraded its rating to a Neutral and also boosted its price target to $17 from $16.50. Previously, DA Davidson downgraded its rating to Underperform on June 05, 2024, and dropped its price target to $17.50. On October 13, 2023, Stephens initiated with a Equal-Weight rating and assigned a price target of $82 on the stock. DA Davidson downgraded its rating to a Neutral and decreased its price target to $106 on November 04, 2022. Jefferies downgraded its rating to a Hold and reduced its price target to $150 on August 04, 2022. Jefferies upgraded its rating to Buy for this stock on January 25, 2021, and upped its price target to $265. In a note dated November 05, 2020, DA Davidson upgraded an Buy rating on this stock and boosted its target price from $180 to $205.
Medifast Inc [MED] stock has fluctuated between $11.57 and $22.66 over the past year. Currently, Wall Street analysts expect the stock to reach $83.5 within the next 12 months. Medifast Inc [NYSE: MED] shares were valued at $14.58 at the most recent close of the market. An investor can expect a potential return of 472.7% based on the average MED price forecast.
Analyzing the MED fundamentals
Medifast Inc [NYSE:MED] reported sales of 543.45M for the trailing twelve months, which represents a drop of -33.77%. Gross Profit Margin for this corporation currently stands at 0.74% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.03 and Total Capital is -0.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.45 points at the first support level, and at 14.31 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.73, and for the 2nd resistance point, it is at 14.89.
Ratios To Look Out For
For context, Medifast Inc’s Current Ratio is 3.52. Further, the Quick Ratio stands at 2.87, while the Cash Ratio is 1.51. Considering the valuation of this stock, the price to sales ratio is 0.29, the price to book ratio is 0.76.
Transactions by insiders
Recent insider trading involved Chard Daniel R, Chairman & CEO, that happened on Jun 13 ’25 when 381.0 shares were purchased.
